Fordham 33 (Report 5): Trade Secrets

Key Takeaways

• Trade secrets complement patents; choice depends on invention type
• AI creates new secrets while exposing existing ones to reverse engineering
• Employee AI training essential to prevent inadvertent trade‑secret disclosure
• DTSA cases surged in decade, reinforcing federal trade‑secret protection
• Debate continues on compulsory licensing of trade secrets during health crises

Pulse Analysis

The interplay between trade secrets and patents remains a cornerstone of intellectual‑property strategy. While patents grant a time‑limited statutory monopoly, trade secrets offer indefinite protection so long as confidentiality is maintained. The Defend Trade Secrets Act of 2016 (DTSA) has cemented federal recourse, and a decade of case law shows a steep increase in litigation, signaling that businesses can no longer rely solely on state‑level safeguards. Companies must assess the nature of their inventions to decide whether a patent’s public disclosure requirement or a trade secret’s secrecy advantage best serves their commercial goals.

Artificial intelligence has reshaped the IP landscape, generating novel proprietary data sets and algorithms that qualify as trade secrets. At the same time, AI’s capacity to scrape, analyze, and reverse‑engineer information threatens existing secrets. Practitioners are therefore urged to implement robust AI‑specific training, enforce strict access controls, and regularly update confidentiality agreements. These measures help mitigate inadvertent disclosures and align employee behavior with evolving legal expectations, ensuring that the flexibility of trade‑secret law can keep pace with rapid technological change.

Public‑health emergencies, such as the COVID‑19 pandemic, have exposed gaps in the current IP framework, particularly the absence of compulsory licensing mechanisms for trade secrets. While patents can be forced into licensing under emergency provisions, trade secrets remain shielded, potentially hindering rapid vaccine production. The panel’s debate reflects a broader policy conversation about balancing innovation incentives with societal needs. Future legislative action may consider limited, transparent licensing pathways for critical trade secrets, a move that could reshape how companies protect and share vital knowledge during crises.